Evaluating a Contactless Monitor for Blood Pressure at Home
Official title: VISION-Real World Evaluation
Run by Xim Limited · NCT06325384 · Data updated 2026-11-12
This study is testing whether a new contactless blood pressure monitor works as well as traditional cuffs for people with high blood pressure who are managing their condition at home.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Xim Limited Industry-sponsored |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | February 10, 2025 |
| Main results expected | October 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | April 3, 2025 |
| Trial ID | NCT06325384 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a clinical diagnosis of uncontrolled hypertension.
✕Probably not a fit
Patients with stage III hypertension or significant arrhythmias may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares the effectiveness of a contactless vital signs monitor, Lifelight®, with traditional blood pressure cuffs for home monitoring in patients with uncontrolled hypertension. Participants aged 18 and older will be recruited from hypertension clinics and randomly assigned to use either the Lifelight® device or a standard BP cuff. Over six months, they will record their blood pressure readings and adherence to the monitoring schedule, while also tracking healthcare resource use and feedback on their monitoring method. The study aims to assess the feasibility and clinical outcomes of these two monitoring approaches.
Why it matters
Potential benefit: If successful, this study could provide a more convenient and effective method for patients to monitor their blood pressure at home.
How similar studies have gone: Other studies have shown promise in using innovative monitoring technologies for hypertension management, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Established diagnosis of hypertension * Uncontrolled hypertension defined as office blood pressure ≥140/90mmHg. * Patients who are pharmacologically treated for their hypertension should have been on stable medication for at least 4 weeks. * Ability to read, write and understand English to complete the study. * Capacity to give free, valid informed consent. * A compatible device that supports Lifelight®, as per xim Ltd.'s constantly updating list of compatible devices. If this is not possible, xim Ltd, might provide a similar device for the purpose of the study. Exclusion Criteria: * Patients with stage III hypertension with office blood pressure ≥180/120mmHg or it is unsafe to keep them in the study, in the opinion of the investigators. * Individuals with diagnosed atrial fibrillation. * Patients with significant arrhythmias such as SVT (Supraventricular tachycardia) or any rhythm that has significant impact on their BP, poor perfusion, pregnancy, pre-eclampsia, deformities or abnormalities which may prevent proper application of a BP cuff, or skin disorders (anaemia, jaundice, rosacea, psoriasis, acute acne, and erythropoietic protoporphyria) * Participants who are unwilling to undertake self-monitoring or lacking capacity. * Partners or spouses of individuals already randomised in the trial * Patients on dialysis or known ESRD (End-stage kidney disease) * Patients on active cancer treatment * Terminally ill patients * Patients who cannot tolerate sitting for up to one hour.
Where it's running
-
William Harvey Heart Centre, Queen Mary Queen Mary University of London, Charterhouse Square,
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Laurence Pearce, BSc, MBA
- Email: laurence@xim.ai
- Phone: 07803950356
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.